Why is Shanghai MicroPort Endovascular MedTech Co., Ltd. ?
1
Negative results in Sep 25
- INTEREST(HY) At CNY 0.86 MM has Grown at 20.97%
- OPERATING CASH FLOW(Y) Lowest at CNY 381.73 MM
- NET PROFIT(9M) At CNY 429.06 MM has Grown at -22.46%
2
With ROE of 10.02%, it has a expensive valuation with a 3.33 Price to Book Value
- Over the past year, while the stock has generated a return of 19.12%, its profits have fallen by -33.7%
- At the current price, the company has a high dividend yield of 1.1
How much should you buy?
- Overall Portfolio exposure to Shanghai MicroPort Endovascular MedTech Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shanghai MicroPort Endovascular MedTech Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shanghai MicroPort Endovascular MedTech Co., Ltd.
1.96%
0.00
32.44%
China Shanghai Composite
23.91%
1.58
14.20%
Quality key factors
Factor
Value
Sales Growth (5y)
19.56%
EBIT Growth (5y)
17.69%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.52
Sales to Capital Employed (avg)
0.31
Tax Ratio
25.31%
Dividend Payout Ratio
49.49%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
74.02%
ROE (avg)
16.77%
Valuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
2.85
EV to EBIT
16.36
EV to EBITDA
14.71
EV to Capital Employed
4.64
EV to Sales
7.16
PEG Ratio
0.64
Dividend Yield
1.38%
ROCE (Latest)
28.34%
ROE (Latest)
13.73%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Technical Movement
13What is working for the Company
NET PROFIT(HY)
At CNY 288.8 MM has Grown at 268.37%
NET SALES(HY)
At CNY 706.09 MM has Grown at 24.1%
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -10% (YoY
-3What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.75 times
DEBT-EQUITY RATIO
(HY)
Highest at -49.05 %
Here's what is working for Shanghai MicroPort Endovascular MedTech Co., Ltd.
Net Profit
At CNY 288.8 MM has Grown at 268.37%
Year on Year (YoY)MOJO Watch
Net Profit trend is very positive
Net Profit (CNY MM)
Net Sales
At CNY 706.09 MM has Grown at 24.1%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Raw Material Cost
Fallen by -10% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shanghai MicroPort Endovascular MedTech Co., Ltd.
Debtors Turnover Ratio
Lowest at 2.75 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Debt-Equity Ratio
Highest at -49.05 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






